Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- ChecktodayChange DetectedFooter now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Locations section now includes Texas as a site and removes the prior separate 'Texas Locations' listing; the footer no longer shows the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check50 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled and may not relate to the study, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check57 days agoChange DetectedThe funding status notice was removed from the page, and the study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedNo meaningful changes detected between the two screenshots of the Study Details page for NCT01585194.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.